Ophthalmologic prevention of chloroquine and hydroxychloroquine induced retinopathy;Prévention ophtalmologique de l'intoxication rétinienne induite par les antipaludéens de synthèse

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 4, 2005, Pages 329-337

  Bui Quoc, E ^a   Ingster Moati, I ^b   Rigolet, M H ^c   Chosidow, O ^d   Bodaghi, B ^d  

^a l'alimentation et l'Environnement   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HYDROXYCHLOROQUINE;

ADULT; CLINICAL EXAMINATION; COLOR VISION TEST; ELECTROOCULOGRAM; ELECTRORETINOGRAM; EYE TOXICITY; FEMALE; HUMAN; MALE; OPHTHALMOSCOPY; PROPHYLAXIS; RETINOPATHY; RETROSPECTIVE STUDY; REVIEW; SCREENING TEST; VISUAL FIELD;

EID: 18744379758     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(05)79277-2     Document Type: Review

References (15)

1. Ingster-Moati I, Crochet M, Manchon E, Lestrade C, Jacob A, Le Brun D, Albuisson E. Surveillance ophtalmologique des patients sous APS au long cours: analyse d'une population de 925 patients. J Fr Ophtalmol 2004;27:367-73.
2. Thorne JE, Maguire AM. Retinopathy after long term, standard doses of hydroxychloroquine. Br J Ophthalmol 1999;83:1201-2.
3. Rynes RI. Ophthalmologic safety of long-term hydroxychloroquine treatment. Am J Med, 1975;1A:35-9.
4. Douche C, Muller JC, Bousquet A. Evaluation à long terme des patients traités par antipaludéens de synthèse. BSOF 1995; n° 3, 198-202.
5. Mavrikakis M, Papazoglou S, Sfikakis PP, Vaiopoulos G, Rougas K. Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis 1996;55:187-9.
6. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997;40:1482-6.
7. Puavilai S, Kunavisarut S, Vatanasuk M, Timpatanapong P, Sriwong ST, Janwitayanujit S, et al. Ocular toxicity of chloroquine among Thai patients. Int J Dermatol 1999;38:934-7.
8. Sundelin SP, Terman A. Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells. APMIS 2002;110:481-9.
9. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2002;109:1377-82.
10. Rigaudiere F, Ingster-Moati I, Hache JC, Leid J, Verdet R, Haymann P, et al. Surveillance ophtalmologique de la prise des antipaludéens de synthèse au long cours: mise au point et conduite à tenir à partir de 2003. J Fr Ophtalmol 2004;27:191-9.
11. François J, de Rouck A, Cambie E, de Laey JJ. Chloroquine retinopathy. Ophthalmologica 1972;165:81-99.
12. Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen AW Jr, Fung WE, Oxford KW. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 2003;23:503-12.
13. So SC, Hedges TR, Schuman JS, Quireza ML. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging 2003;34:251-8.
14. Kellner U, Kraus H, Foerster MH. Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol 2000;238:94-7.
15. Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 2003;22:3927-36.